Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents.
Eleonora NicolòPaolo TarantinoOriana D'EcclesiisGabriele AntonarelliLuca Boscolo BieloAntonio MarraSara GandiniEdoardo CriminiFederica GiuglianoPaola ZagamiChiara CortiDario TrapaniStefania MorgantiCarmen CriscitielloMarzia LocatelliCarmen BelliAngela EspositoIda MinchellaMassimo CristofanilliSara M TolaneyCurigliano GiuseppePublished in: The oncologist (2023)
Higher BTS is associated with worse survival outcomes among patients receiving biomarker-matched, but not biomarker-unmatched TT.
Keyphrases